Ann: DurAVR First in Human Study 12 Month Results, page-16

Hi Disaster,

From the report you shared.

“The investigators concluded that approximately one-third of patients undergoing TAVR failed to improve their exercise capacity after the procedure. The lack of functional improvement after TAVR was predicted by a mix of baseline and periprocedural factors translating into poorer clinical outcomes.”

Plus, this is a 6 month report and after that typically patients get worse not better. Ours improved a further 17% from 30 days to 12 months! Not to mention that some of our patients were older and actually on their death bed. One patient had 2 to 3 weeks to live and now has normal valve function. Amazing.

I think this is keeping it real.